{
    "Alice Smith": {
        "PostmenopausAL heaLth And DIseAse (PALLADIA) Study": "{\n  \"trialId\": \"NCT04995276\",\n  \"match\": true,\n  \"eligibilityCriteriaMet\": \"Patient does not match the trial inclusion criteria as she is not a postmenopausal woman.\"\n}",
        "Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)": "{\n    \"trialId\": \"NCT06100276\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"Confirmed clinical and genetic diagnosis of SOD1-mediated ALS (SOD1-ALS) experiencing signs and/or symptoms of lower motor neuron dysfunction\": false,\n        \"ALSFRS-R score ≥ 25 at Screening\": false,\n        \"Slow vital capacity (SVC) ≥50% of predicted normal value\": false,\n        \"Capable of providing informed consent and complying with trial procedures, medically able to undergo lumbar puncture, and has a responsible caregiver able to attend all clinic visits with the Participant\": false\n    }\n}  ",
        "PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband": "{\n    \"trialId\": \"NCT05690776\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"age\": true,\n        \"condition\": false,\n        \"medication\": false,\n        \"otherCriteria\": false\n    }\n}",
        "Preterm Birth Cohort Study in Guangzhou": "{\n    \"trialId\": \"NCT03668327\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"Born before 37 weeks of gestation\": false,\n        \"Born in Guangzhou Women and Children's Medical Center\": false,\n        \"Intended to remain in Guangzhou for more than 3 years\": false\n    }\n}",
        "Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.": "{\n    \"trialId\": \"NCT03869476\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"age\": true,\n        \"diagnosis\": false,\n        \"treatmentHistory\": false,\n        \"consent\": true\n    }\n}",
        "Quantitative Computed Tomography for Mortality Risk Stratification in ARDS": "{\n    \"trialId\": \"NCT06113276\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": \"Patient does not have ARDS (Acute Respiratory Distress Syndrome) according to the Berlin definition, so does not meet the inclusion criteria\"\n}",
        "Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy": "{\n    \"trialId\": \"NCT06597227\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"ageRequirement\": \"Met\",\n        \"genderRequirement\": \"Not specified\",\n        \"conditionsRequirement\": \"Not met\",\n        \"medicationsRequirement\": \"Not specified\"\n    }\n}"
    },
    "Bob Johnson": {
        "PostmenopausAL heaLth And DIseAse (PALLADIA) Study": "{\n    \"trialId\": \"NCT04995276\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"postmenopausal\": false,\n        \"genderExclusion\": true\n    }\n}",
        "Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)": "{\n  \"trialId\": \"NCT06100276\",\n  \"match\": false,\n  \"eligibilityCriteriaMet\": {\n    \"Confirmed clinical and genetic diagnosis of SOD1-mediated ALS (SOD1-ALS) experiencing signs and/or symptoms of lower motor neuron dysfunction\": false,\n    \"ALSFRS-R score ≥ 25 at Screening\": false,\n    \"Slow vital capacity (SVC) ≥50% of predicted normal value\": false,\n    \"Capable of providing informed consent and complying with trial procedures, medically able to undergo lumbar puncture, and has a responsible caregiver able to attend all clinic visits with the Participant\": false\n  }\n}",
        "PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband": "\n{\n    \"trialId\": \"NCT05690776\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": [\n        \"Older than 18 years\",\n        \"Willing and able to comply with the study procedures\",\n        \"Subject capable of understanding the doctor's explanations, following instructions, and participating in the follow-up program\",\n        \"Subject able to read and understand the ICF and has provided written informed consent\"\n    ]\n}",
        "Preterm Birth Cohort Study in Guangzhou": "{\n    \"trialId\": \"NCT03668327\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"bornBefore37WeeksGestation\": false,\n        \"bornInGuangzhouMedicalCenter\": false,\n        \"intendToRemainInGuangzhouFor3Years\": false\n    }\n}",
        "Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.": "{\n  \"trialId\": \"NCT03869476\",\n  \"match\": false,\n  \"eligibilityCriteriaMet\": \"Patient does not meet the inclusion criteria for the clinical trial as he does not have the diagnosis of essential thrombocytosis, prefibrotic myelofibrosis or overt myelofibrosis according to WHO 2016 criteria.\"\n}",
        "Quantitative Computed Tomography for Mortality Risk Stratification in ARDS": "{\n    \"trialId\": \"NCT06113276\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"age\": true,\n        \"conditions\": true,\n        \"medications\": false\n    }\n}",
        "Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy": "{\n    \"trialId\": \"NCT06597227\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": \"The patient does not meet the inclusion criteria for this clinical trial as the trial is for locally advanced upper gastric cancer patients after neoadjuvant therapy, while the patient has asthma and is not within the age range of 18-75 years old.\"\n}"
    },
    "Emily Brown": {
        "PostmenopausAL heaLth And DIseAse (PALLADIA) Study": "{\n    \"trialId\": \"NCT04995276\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"Age\": false,\n        \"Gender\": false\n    }\n}",
        "Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)": "{\n  \"trialId\": \"NCT06100276\",\n  \"match\": false,\n  \"eligibilityCriteriaMet\": [\n    \"Confirmed clinical and genetic diagnosis of SOD1-mediated ALS (SOD1-ALS) experiencing signs and/or symptoms of lower motor neuron dysfunction\"\n  ]\n}",
        "PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband": "{\n  \"trialId\": \"NCT05690776\",\n  \"match\": false,\n  \"eligibilityCriteriaMet\": \"Age requirement not met\"\n}",
        "Preterm Birth Cohort Study in Guangzhou": "{\n    \"trialId\": \"NCT03668327\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"age\": false,\n        \"location\": false,\n        \"conditions\": false,\n        \"medications\": false\n    }\n}",
        "Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.": "{\n    \"trialId\": \"NCT03869476\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": \"Patient does not qualify due to not having the diagnosis of essential thrombocytosis, prefibrotic myelofibrosis or overt myelofibrosis as per WHO 2016 criteria.\"\n}  ",
        "Quantitative Computed Tomography for Mortality Risk Stratification in ARDS": "{\n    \"trialId\": \"NCT06113276\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": {\n        \"ageRange\": true,\n        \"inclusionCriteria\": false,\n        \"exclusionCriteria\": false\n    }\n}",
        "Proximal Gastrectomy Vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy": "{\n    \"trialId\": \"NCT06597227\",\n    \"match\": false,\n    \"eligibilityCriteriaMet\": \"Not met\"\n}"
    }
}